Novel Gemcitabine Conjugated Albumin Nanoparticles: A Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment

Pharmaceutical Research - United States
doi 10.1007/s11095-017-2238-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Paclitaxel-Loaded Polyphosphate Nanoparticles: A Potential Strategy for Bone Cancer Treatment

Journal of Materials Chemistry B
MedicineMaterials ScienceChemistryBiomedical Engineering
2014English

Doxorubicin-Loaded CuS Nanoparticles Conjugated With GFLG: A Novel Drug Delivery System for Lymphoma Treatment

Nano
Materials ScienceNanotechnologyCondensed Matter PhysicsNanoscience
2019English

Curaxin CBL0137 Eradicates Drug Resistant Cancer Stem Cells and Potentiates Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

Oncotarget
Oncology
2014English

Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models

Oncotarget
Oncology
2015English

Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer

Suizo
2007English

Mechanistic Multi‐scale Pharmacokinetic Model for the Anticancer Drug Gemcitabine in Pancreatic Cancer

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

Minnelide, a Novel Drug for Pancreatic and Liver Cancer

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2015English

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Targeting the Warburg Effect With a Novel Glucose Transporter Inhibitor to Overcome Gemcitabine Resistance in Pancreatic Cancer Cells

Carcinogenesis
MedicineCancer Research
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy